Nussler N C, Hoffman R A, McCarthy S A, Simmons R L
Department of Surgery, University of Pittsburgh, PA 15261, USA.
Int Immunol. 1996 Nov;8(11):1767-77. doi: 10.1093/intimm/8.11.1767.
While the pathological characteristics of acute graft versus host disease (GvHD) have been defined for many target organs, little attention has been paid to the functional changes to lymphocytes in target organs such as the liver and small intestine. We have shown previously, utilizing a nonlethal parent (C57BL/6J) into the F1 (C57BL/6J x DBA2J F1) GvHD model, that the intestinal mucosa is infiltrated exclusively by donor T cells with a CD8+ phenotype during the first 3 weeks post-GvHD induction. The present study investigated the functional changes associated with the phenotypic changes of intestinal intraepithelial lymphocytes (IEL) during the acute phase of GvHD. IEL displayed specific anti-host cytolytic activity during the second and third week after GvHD induction. In addition, enhanced cytolytic activity, detected in the presence of anti-CD3 antibody, was apparent during the second through fourth week, with a peak in the third week after GvHD induction. The IEL also showed enhanced proliferative responses to immobilized anti-CD3 during the first 2 weeks of acute GvHD, while profound inhibition of proliferation was observed in the splenocyte population of the same animals. During weeks 2 and 3 post-GvHd induction, the V beta distribution of host IEL remained unchanged while the V beta distribution of infiltrating donor CD8+ cells resembled that of the donor IEL population. In the small intestine, the increased cytolytic and proliferative activity of IEL during the course of the disease may provide a rationale for the involvement of this organ in the pathology associated with GvHD.
虽然急性移植物抗宿主病(GvHD)的病理特征在许多靶器官中已有明确界定,但对于肝脏和小肠等靶器官中淋巴细胞的功能变化却鲜有研究。我们之前利用非致死性亲代(C57BL/6J)至F1(C57BL/6J×DBA2J F1)的GvHD模型发现,在GvHD诱导后的前3周,肠道黏膜仅被具有CD8+表型的供体T细胞浸润。本研究调查了GvHD急性期肠道上皮内淋巴细胞(IEL)表型变化相关的功能改变。在GvHD诱导后的第二和第三周,IEL表现出特异性的抗宿主细胞溶解活性。此外,在抗CD3抗体存在的情况下检测到的增强的细胞溶解活性在第二至第四周明显,在GvHD诱导后的第三周达到峰值。在急性GvHD的前2周,IEL对固定化抗CD3的增殖反应也增强,而在同一只动物的脾细胞群体中观察到增殖受到显著抑制。在GvHD诱导后的第2周和第3周,宿主IEL的Vβ分布保持不变,而浸润的供体CD8+细胞的Vβ分布与供体IEL群体相似。在小肠中,疾病过程中IEL细胞溶解和增殖活性的增加可能为该器官参与与GvHD相关的病理过程提供了一个解释。